Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)-Reference-Cited by-同舟云学术

Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)

Published:2009-08 Issue:8 Volume:49 Page:947-956
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Li Jian-Jun,Lu Zong-Liang,Kou Wen-Rong,Chen Zuo,Wu Yang-Feng,Yu Xue-Hai,Zhao Yu-Cheng,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Sudden cardiac death: epidemiology, mechanisms, and therapy;Turakhia;Curr Probl Cardiol,2007

2. Increasing burden of cardiovascular disease: current knowledge and future direction for research on risk factors;Hennekens;Circulation,1998

3. Cardiovascular risk factors in the elderly;Casteli;Am J Cardiol,1989

4. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark study;Njolstad;Circulation,1996

5. Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO study;Sicard;Am J Hypertens,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases;Acta Pharmaceutica Sinica B;2024-05

2. Associations between the use of red yeast rice preparations and adverse health outcomes: An umbrella review of meta-analyses of randomized controlled trials;Journal of Integrative Medicine;2024-03

3. Alternative lipid lowering strategies: State-of-the-art review of red yeast rice;Fitoterapia;2024-01

4. Alimentos funcionales y nutracéuticos en el tratamiento de la hipercolesterolemia: posicionamiento de la Sociedad Española de Arteriosclerosis 2023;Clínica e Investigación en Arteriosclerosis;2023-09

5. Functional foods and nutraceuticals in the treatment of hypercholesterolemia: Statement of the Spanish Society of Arteriosclerosis 2023;Clínica e Investigación en Arteriosclerosis (English Edition);2023-09